Dosimetric comparison of peripheral NSCLC SBRT using Acuros XB and AAA calculation algorithms
Keywords: سرطان ریوی غیر سلول کوچک; SBRT; AXB; AAA; Calculation algorithms; NSCLC;
مقالات ISI سرطان ریوی غیر سلول کوچک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Knocking down MiR-15a expression promotes the occurrence and development and induces the EMT of NSCLC cells in vitro
Keywords: سرطان ریوی غیر سلول کوچک; miR-15a; EMT; NSCLC;
Phase II randomised trialHeterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; Dose-escalation; Randomized phase-III trial;
Original ArticleUpregulation of vascular endothelial growth factor (VEGF), its role in progression and prognosis of non-small cell lung carcinoma
Keywords: سرطان ریوی غیر سلول کوچک; VEGF; progression; prognosis; NSCLC;
Long noncoding RNA activated by TGF-β in human cancers: A meta-analysis
Keywords: سرطان ریوی غیر سلول کوچک; ATB; activated by TGF-β; HR; hazard ratio; CI; confidence interval; OR; odds ratio; CRC; colorectal cancer; NSCLC; non-small cell lung cancer; PRC; pancreatic cancer; GC; gastric cancer; RCC; renal cell carcinoma; PSC; prostate carcinoma; HCC; hepatocell
PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; PAI-1; microRNAs; miR-34a; Stat3; NSCLC; Metastasis;
Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; AJCC; American Joint Committee on Cancer; ANA; antinuclear antibody; CI; confidence intervals; EGFR; epidermal growth factor; HR; hazard ratio; ISR; injection site reactions; ITT; intent-to-treat; mITT; modified intent-to-treat; MUC1; mucin 1; NSCLC; non-
Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; PD-L1; PD-1 ligand; NSCLC; non-small cell lung cancer; SNPs; single nucleotide polymorphisms; PD-1; programed cell death-1; CTLA-4; cytotoxic T lymphocyte-associated antigen 4; OS; overall survival; IHC; immunohistochemistry; HRs; hazard ratios; HWE; Hard
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression
Keywords: سرطان ریوی غیر سلول کوچک; miRNA; microRNA; mRNA; messenger RNA; cDNA; coding DNA; BC; breast cancer; NSCLC; non-small cell lung cancer; ld; low-differentiated; md; moderate-differentiated; hd; high-differentiated; qPCR; quantitative PCR; MSP; methylation-specific PCR; rs; Spearman
Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer
Keywords: سرطان ریوی غیر سلول کوچک; MicroRNA-34; MicroRNA-124; MSP; NSCLC; Prognosis;
Original StudyEstablishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center
Keywords: سرطان ریوی غیر سلول کوچک; Adjusted prognosis analysis model; BMs; Epidermal growth factor receptor; NSCLC; Survival model;
Therapeutic strategies and mechanisms of drug resistance in anaplastic lymphoma kinase (ALK)-rearranged lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; ALK; Fusion gene; Resistance; Mutation; Tyrosine kinase inhibitor; ALK; Anaplastic lymphoma kinase; TKI; Tyrosine kinase inhibitors; ALCL; Anaplastic large-cell non-Hodgkin's lymphoma; NB; Neuroblastoma; NSCLC; Non-small cell lung cancer; NPM; Nucleophosm
Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma
Keywords: سرطان ریوی غیر سلول کوچک; lung adenocarcinoma; epidermal growth facter receptor; gene mutation; prognosis; CEA; carcinoembryonic antigen; CI; confidence interval; CT; computed tomography; EGFR; epidermal growth factor receptor; MRI; magnetic resonance imaging; NSCLC; non-small c
miR-205 as a biological marker in non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; MiR-205; NSCLC; Biological activity; Biological marker;
β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; non-small-cell lung cancer; ER; endoplasmic reticulum; ERs; endoplasmic reticulum stress; 4-PBA; 4-phenylbutyric acid; WB; western blotting; q-PCR; quantitative reverse transcription polymerase chain reaction; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-
Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis
Keywords: سرطان ریوی غیر سلول کوچک; SBRT; NSCLC; TCP;
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; non-small cell lung cancer; TKI; tyrosine kinase inhibitor; PFS; progression-free survival; SARMS; Scorpion Amplification Refractory Mutation System; dPCR; digital polymerase chain reaction; ddPCR; picodroplet dPCR; mCRC; metastatic colorectal ca
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; ILD; interstitial lung disease; EGFR; epidermal growth factor receptor; TKIs; tyrosine-kinase inhibitors; PD-1; programmed cell death-1; NSCLC; non-small-cell lung cancer; RECIST; Response Evaluation Criteria in Solid Tumors; CT; chest computed tomography
TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; non-small cell lung carcinoma; CsnB; cytosporone B; Hif-1α; hypoxia-inducible factor-1α; Non-small cell lung cancer; Hypoxia; Apoptosis; TR3; HIF-1α; Cytosporone B;
MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA
Keywords: سرطان ریوی غیر سلول کوچک; miR-33a; METTL3; Proliferation; NSCLC; EGFR;
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
Keywords: سرطان ریوی غیر سلول کوچک; LC; lung cancer; ILD; interstitial lung disease; HRCT; high-resolution computed tomography; AE; acute exacerbation; DAD; diffuse alveolar damage; IPF; idiopathic pulmonary fibrosis; PS; performance status; ECOG; Eastern Cooperative Oncology Group; NSCLC;
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer
Keywords: سرطان ریوی غیر سلول کوچک; EGFR; epidermal growth factor receptor; LCNEC; large cell neuroendocrine carcinoma; NGS; next-generation sequencing; NSCLC; non-small cell lung cancer; SCLC; small cell lung cancer; TKI; tyrosine kinase inhibitor;
Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; T-cells; Transcription factors; Lung cancer; Checkpoint antigens; PD-1; CTLA4;
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
Keywords: سرطان ریوی غیر سلول کوچک; Phase Ib; Afatinib; Cetuximab; NSCLC; EGFR;
Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; Cardiac toxicity; Chemoradiation; Dose escalation;
ReviewUncommon EGFR mutations in advanced non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; Uncommon; EGFR mutations; Tyrosine kinase inhibitors;
Cigarette smoke extract induces EGFR-TKI resistance via promoting EGFR signaling pathway and ROS generation in NSCLC cell lines
Keywords: سرطان ریوی غیر سلول کوچک; CSE; EGFR-TKI resistance; ROS; Oxidative stress; NSCLC;
Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC
Keywords: سرطان ریوی غیر سلول کوچک; Olaratumab; NSCLC; PDGFR; Paclitaxel/carboplatin;
Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: AÂ Propensity-Matched Analysis
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; Natural history; Untreated; Surgery; Radiation; Chemotherapy;
Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome After Pneumonectomy
Keywords: سرطان ریوی غیر سلول کوچک; ADC; adenocarcinoma; ANOVA; analysis of variance; ARDS; acute respiratory distress syndrome; ASA; American Society of Anesthesiologists; BMI; body mass index; COPD; chronic obstructive pulmonary disease; Dlco; diffusing capacity of the lung for carbon mon
Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study
Keywords: سرطان ریوی غیر سلول کوچک; ALK; Anaplastic Lymphoma Kinase; BMI; body mass index; CCI; Charlson Comorbidity Index; CI; confidence interval; CR; complete response; CRISP; clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patien
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification
Keywords: سرطان ریوی غیر سلول کوچک; MET-inhibitor; Advanced solid tumours; NSCLC; MET-amplified; Phase I; Dose escalation;
MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
Keywords: سرطان ریوی غیر سلول کوچک; ADR; adriamycin; miRNA; microRNA; UTR; untranslated region; PTEN; phosphatase a tensin homolog deleted on chromosome 10; PIP3; phosphatidylinositol-3,4,5-triphosphate; PIP2; diphosphate product; IC50; the inhibitory concentration to produce 50% cell death
A CBR framework with gradient boosting based feature selection for lung cancer subtype classification
Keywords: سرطان ریوی غیر سلول کوچک; Case-based reasoning; Gradient boosting; NSCLC; Biomarker; Microarray;
LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; LSD1; lysine specific demethylase 1; KDM; lysine demethylase; SCLC; small cell lung cancer; NSCLC; non-small cell lung cancer; LSD1; LSD1+8a; KDM; SCLC; Neuroendocrine marker; Resistance to chemotherapy;
MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; miR-770; miRNAs; JMJD6; WNT/β-catenin; NSCLC;
MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2
Keywords: سرطان ریوی غیر سلول کوچک; miR-542-3p; FTSJ2; NSCLC; Up-regulated; EMT;
miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells
Keywords: سرطان ریوی غیر سلول کوچک; miRNAs; microRNAs; OS; osteosarcoma; EMT; epithelial-to-mesenchymal transition; ESCC; esophageal squamous carcinoma; FBXW7; F-box and WD repeat domain-containing 7; NSCLC; non-small cell lung cancer; HCC; hepatocellular carcinoma; PTEN; phosphatase and te
Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study
Keywords: سرطان ریوی غیر سلول کوچک; Docetaxel; Gemcitabine; NSCLC; Elderly patients;
Original articleImplication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma
Keywords: سرطان ریوی غیر سلول کوچک; miR-375; microRNA-375; TCGA; Cancer Genome Atlas; GEO; Gene Expression Omnibus; KEGG; Kyoto Encyclopedia of Genes and Genomes; NSCLC; non-small-cell lung cancer; LUAD; lung adenocarcinoma; LUSC; lung squamous cell carcinoma l; miRNAs; MicroRNAs; YAP1; yes
Research paperInter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas
Keywords: سرطان ریوی غیر سلول کوچک; PSC; pulmonary sarcomatoid carcinoma; NSCLC; non-small cell lung cancer; NGS; next-generation sequencing; Pulmonary sarcomatoid tumor; Pulmonary carcinosarcoma; PD-L1; Immunotherapy; Immunohistochemistry; Mutational burden;
Original ResearchApatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; Apatinib; Gefitinib; EGFR; VEGFR;
Original ArticleFeedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression
Keywords: سرطان ریوی غیر سلول کوچک; Aldolase A; Lung cancer metastasis; HIF-1α stabilization; Proline-hydroxylase; MMP9; ALDOA; aldolase A; HIF-1α; Hypoxia-inducible factor 1 alpha; PHD; proline-hydroxylase; IHC; immunohistochemical; NSCLC; non-small cell lung cancer; IPA; Ingenuity Path
Mini-reviewEGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs
Keywords: سرطان ریوی غیر سلول کوچک; EGFR T790M mutation; Tyrosine kinase inhibitors; NSCLC; Drug resistance;
Mini-reviewPD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges
Keywords: سرطان ریوی غیر سلول کوچک; PD1; PD-L1; NSCLC; Efficacy; Challenges; PD-1; programmed death-1; PD-L1; programmed death ligand-1; NSCLC; Non-small cell lung cancer; ORR; overall response rate; DOR; duration of response; OS; overall survival; PFS; progression free survival; AE; advers
ReviewImmunotherapy Comes of Age in Lung Cancer
Keywords: سرطان ریوی غیر سلول کوچک; Immune checkpoints; NSCLC; PD-1; PD-L1; SCLC;
A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib
Keywords: سرطان ریوی غیر سلول کوچک; Anaplastic lymphoma kinase; NSCLC; Companion diagnostic assay; ALK IHC; Targeted therapy;
Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway
Keywords: سرطان ریوی غیر سلول کوچک; CTN; Compounds of tanshinone; DMSO; Dimethyl sulfoxide; EDTA; Ethylene diamine tetraacetic acid; HPLC; High performance liquid chromatography; MTT; 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; NSCLC; Human non-small cell lung cancer; PAR
The HRH4 rs11662595 mutation is associated with histamine H4 receptor dysfunction and with increased epithelial-to-mesenchymal transition progress in non-small cell lung cancer
Keywords: سرطان ریوی غیر سلول کوچک; CI; confidential interval; EMT; epithelial-to-mesenchymal transition; HR; hazard ratio; HRH4; histamine H4 receptor; MAF; minor allele frequency; NSCLC; Non-small cell lung cancer; OS; overall survival; PFS; progression-free survival; SNP; single-nucleoti
Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway
Keywords: سرطان ریوی غیر سلول کوچک; NSCLC; Non-small cell lung cancer; Nox2; nicotinamide adenine dinucleotide phosphate oxidase 2; ROS; reactive oxygen species; NAC; N-acetyl cysteine; Bim; B-cell lymphoma 2 interacting mediator of cell death; Erlotinib; Ampelopsin; ROS; Nox2; NSCLC;